Pinned Tweet
Thanks to an amazing effort by a fantastic international team, version 2 of the #Cochrane tool for assessing risk of bias in #randomized #trials (#ROB2) has just been published in @bmj_latest. Download from bmj.com/cgi/content/full/bmj… @_MiguelHernan
Jonathan Sterne retweeted
🎉 Celebrating what we've achieved in 2025! 🎉
🥳 See the top news stories of the year from our research themes 👇
📰 Read all our news of 2025 at bristolbrc.nihr.ac.uk/news/
#diet #PhysicalActivity #SurgicalInnovation #MentalHealth #DataScience #RespiratoryDisease
Jonathan Sterne retweeted
🚨 Funded PhD opportunity 🚨 Work with large-scale electronic health record data from #OpenSAFELY to optimise vaccine effectiveness estimation for respiratory viruses.
Apply here 👉findaphd.com/phds/project/op…
Jonathan Sterne retweeted
A great privilege to have Prof @jonathanasterne at @PainIMPACTNeuRA to talk about assessing risk of bias in randomised trials using the RoB 2 tool.
Jonathan Sterne retweeted
We're off and away with Summer School 2025!
Jonathan Sterne is leading our Advanced causal inference course, ably assisted by tutors Ghazaleh Dashti, Marnie Downes, Daisy Shepherd and Jiaxin Zhang from CEBU.
PS. Follow us over on @vicbiostat.bsky.social..
Jonathan Sterne retweeted
1/
That "immortal time" is so frequent in survival analyses for #causalinference is fascinating.
Because "immortal time" doesn't exist in the data, *we* create it when misanalyzing data.
Our paper pubmed.ncbi.nlm.nih.gov/3949… summarizes why immortal time arises & how to prevent it.
Jonathan Sterne retweeted
New Year training goals? Explore our online intensive short courses for researchers and healthcare researchers - search Bristol Medical School short courses for more info.
Jonathan Sterne retweeted
The @CAUSALab Methods Series at @karolinskainst is back!
@jonathanasterne @BristolUni kicks off Fall 2024 with a virtual talk on COVID-19 vaccine effectiveness & OpenSAFELY.
Register to attend 👇
stats.sender.net/forms/e7JD1…
#causalinference #targettrial #publichealth #causal
Jonathan Sterne retweeted
📢New paper in @JAMAPsych
Incidence of mental illnesses in unvaccinated people increased for up to one year after severe COVID-19. Findings suggest vaccination may mitigate effects of the disease on #MentalHealth
News tinyurl.com/24aaejz2
Paper tinyurl.com/3jjrafce
Jonathan Sterne retweeted
Our latest research:Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England. Led by Samantha Ip @venexia @jonathanasterne &Angela Wood. Supporting wide uptake of future COVID-19 vaccination programs. nature.com/articles/s41467-0…
Jonathan Sterne retweeted
Fab to work with @KurtSci1994 @venexia @jonathanasterne Nish Chaturvedi @MRCLHA Rachel Denholm & others @OpenSAFELY showing post-covid T2DM less likely after vaccination sciencedirect.com/science/ar…
Jonathan Sterne retweeted
Our Director's Fund is supporting 3 new projects looking at predicting postoperative complications, empowering young people in their #Digital lives + improving pleural #Mesothelioma prediction.
Congratulations @drrichstrong, @LucyABiddle + Geri Lynch!
News tinyurl.com/ye27de34
Jonathan Sterne retweeted
The @TARGETGuideline team needs your help.
If you work on #causalinference from observational data, please get involved in piloting the reporting guidelines for #TargetTrial emulation.
Diverse viewpoints will make the guidelines more useful for everyone in #RWE.
More info👇
It was great to welcome the @TARGETGuideline team to @HarvardChanSPH to reach consensus on items for a #ReportingGuideline for target trial emulation. We look forward to the guideline being piloted and released in the coming year
Sign up to contribute via redcap.link/target-piloting
Jonathan Sterne retweeted
📢New collaborative project on our site!
'Handling missing data in large electronic healthcare record datasets'
Led by Prof Angela Wood from @Cambridge_Uni, @jonathanasterne + Prof Kate Tilling
Partnering with @BHFDataScience + @HDR_UK
Project page tinyurl.com/427cx8jw
Jonathan Sterne retweeted
New @NatureMedicine
The longest randomized trial assessment—4 years— of semaglutide (Wegovy) in participants without diabetes
nature.com/articles/s41591-0…
Sustained weight loss, no new side effects noted
Jonathan Sterne retweeted
The 17th Kolokotrones Symposium, "UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence,” was a success!
Thanks to our speakers for providing valuable insight into the British data model.
Presentations now live on YouTube:
youtu.be/OkK57xqPOoI?si=786C…
Jonathan Sterne retweeted
📢Paper alert!
Read about ROBINS-E, a new tool for assessing risk of bias in observational studies of exposures. Paper by Prof Julian PT Higgins, @jonathanasterne + rest of international team published in @env_int_journal
News tinyurl.com/29ac5sja
Paper tinyurl.com/35f5ehcm
Jonathan Sterne retweeted
Replying to @_MiguelHernan
@_MiguelHernan & @jonathanasterne kick off the 17th Kolokotrones Symposium - UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence.
Check out today's agenda and follow along as we live tweet the event!
causalab.sph.harvard.edu/sym…
Jonathan Sterne retweeted
Excited to be part of the Bristol-Bordeaux Public Health Meeting 2024! Looking forward to the diverse set of talks over the next two days to facilitate research and training collaboration. #UB2PH2024
Jonathan Sterne retweeted
Compared with no invitation for routine PSA testing, a single invitation for a PSA screening test reduced prostate cancer mortality at a median follow-up of 15 years, but the absolute mortality benefit was small.
ja.ma/43J43q3
#EAU24































